As the respiratory illness season begins, cases of respiratory syncytial virus (RSV) cases are rising in Canada. But new tools offers hope for prevention.

Background: Since its introduction, palivizumab has been used to prevent respiratory syncytial virus (RSV) infection in high-risk populations. Recommendations for palivizumab administration ...

Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM; USA, France, Germany, Italy.

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

A breast cancer drug - which keeps the disease stable for up to four times longer than the previous treatment - will be ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...

High levels of neutralizing antibodies to RSV F protein have been shown to correlate with protection from RSV disease in infants and the elderly, and the clinical effectiveness of palivizumab and ...

Thanks to the introduction of new monoclonal antibodies and vaccines. The respiratory syncytial virus (RSV) prophylaxis ...

Cover the mouth and nose while coughing. Avoid exposure to tobacco smoke. When possible, avoid or restrict group settings during RSV season. Your child may be prescribed a medication known as ...